Literature DB >> 6381546

Nature of non-B, non-T lymphomas: an immunohistological study on frozen tissues using monoclonal antibodies.

G Pallesen, P C Beverley, E B Lane, M Madsen, D Y Mason, H Stein.   

Abstract

In a previous study employing conventional immunological marker analysis we found that 17% of high grade malignant lymphomas were devoid of cytoplasmic and membrane immunoglobulin and also sheep erythrocyte receptors. Cryostat sections from 24 of these cases (four of low grade and 20 of high grade malignancy) were stained with a panel of 30 monoclonal antibodies and six polyclonal antisera using a sensitive immunoperoxidase method. All tumours expressed the leucocyte common antigen (detected by monoclonal antibody 2D1) and all lacked epithelial cytokeratin (monoclonal antibody LE61), confirming their haematopoietic origin. All but one of the lymphomas expressed antigens characteristic of either B cells (17 cases) or T cells (six cases), while one case (morphologically a centroblastic lymphoma) had an unusual dual phenotype in which strong staining for T6 (marker of immature T cells) was associated with expression of the pan B lymphocyte antigens detectable with To15, anti-B1, anti-Leu12. This case was therefore classified as a B cell lymphoma showing aberrant expression of the T6 antigen. The pan B cell antibodies (To15, anti-B1, anti-Leu12) all appeared highly specific and sensitive, but the simultaneous use of all three monoclonal antibodies was necessary to detect the B cell nature in each of the 18 lymphomas. A wider panel of monoclonal antibodies was required to detect T lymphomas since these often disclosed atypical and restricted phenotypes. To15 and UCHT1 were the most reliable antibodies for the detection of B and T cell neoplasms, respectively. We conclude that most, if not all, "non-B, non-T" lymphomas are of either B or T lymphocyte origin and that monoclonal antibodies provide indispensable tools in their classification and diagnosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381546      PMCID: PMC498891          DOI: 10.1136/jcp.37.8.911

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Characterization of a human B lymphocyte-specific antigen.

Authors:  P Stashenko; L M Nadler; R Hardy; S F Schlossman
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

2.  Immunologic phenotype in 30 patients with diffuse large-cell lymphoma.

Authors:  R Warnke; R Miller; T Grogan; M Pederson; J Dilley; R Levy
Journal:  N Engl J Med       Date:  1980-08-07       Impact factor: 91.245

3.  A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).

Authors:  T Abo; C M Balch
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

4.  Distinctive functional characteristics of human "T" lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody.

Authors:  P C Beverley; R E Callard
Journal:  Eur J Immunol       Date:  1981-04       Impact factor: 5.532

5.  A monoclonal antibody reactive with human peripheral blood monocytes.

Authors:  J Breard; E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

6.  Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage.

Authors:  J Ritz; L M Nadler; A K Bhan; J Notis-McConarty; J M Pesando; S F Schlossman
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

7.  A new human T-cell differentiation antigen: unexpected expression on chronic lymphocytic leukemia cells.

Authors:  P J Martin; J A Hansen; R C Nowinski; M A Brown
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

8.  Differential diagnosis of malignant lymphoma and nonlymphoid tumors using monoclonal anti-leucocyte antibody.

Authors:  G Pizzolo; J Sloane; P Beverley; J A Thomas; K F Bradstock; S Mattingly; G Janossy
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

9.  Surface marker and histopathologic correlation with long-term survival in advanced large-cell non-Hodgkin's lymphoma.

Authors:  R A Rudders; E T Ahl; R A DeLellis
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

10.  Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen.

Authors:  R L Evans; D W Wall; C D Platsoucas; F P Siegal; S M Fikrig; C M Testa; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

View more
  8 in total

1.  Primary mediastinal clear cell lymphoma of B-cell type.

Authors:  P Möller; B Lämmler; M Eberlein-Gonska; G E Feichter; W J Hofmann; H Schmitteckert; H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

2.  Unusual immunophenotype displayed by histiocytes in haemophagocytic lymphohistiocystosis.

Authors:  T Herlin; G Pallesen; T Kristensen; N Clausen
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

3.  Cutaneous lymphoma expressing both T-cell and macrophage features.

Authors:  J Adams; C M Ridley; C M Collins; P G Isaacson
Journal:  J R Soc Med       Date:  1984       Impact factor: 5.344

4.  Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma.

Authors:  G Pallesen; S J Hamilton-Dutoit
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

5.  Distribution of the Burkitt's lymphoma-associated antigen (BLA) in normal human tissue and malignant lymphoma as defined by immunohistological staining with monoclonal antibody 38.13.

Authors:  G Pallesen; J Zeuthen
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

6.  Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues.

Authors:  S K Moestrup; J Gliemann; G Pallesen
Journal:  Cell Tissue Res       Date:  1992-09       Impact factor: 5.249

7.  The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression.

Authors:  P Möller; B Lämmler; B Herrmann; H F Otto; G Moldenhauer; F Momburg
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

8.  Novel primary thymic defect with T lymphocytes expressing gamma delta T cell receptor.

Authors:  C Geisler; G Pallesen; P Platz; N Odum; E Dickmeiss; L P Ryder; A Svejgaard; T Plesner; J K Larsen; C Koch
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.